Literature DB >> 20865059

MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation.

Lei Huang1, Xiaodong Liao, Michael Beckett, Yuan Li, Kum Kum Khanna, Zhugang Wang, Surender Kharbanda, Ralph Weichselbaum, Donald Kufe.   

Abstract

The ataxia-telangiectasia mutated (ATM) kinase is activated in the cellular response to ionizing radiation (IR) and is of importance to the repair of DNA double strand breaks (DSBs). The MUC1 oncoprotein is aberrantly overexpressed in human breast carcinomas. The present work demonstrates that the MUC1 C-terminal subunit (MUC1-C) constitutively interacts with ATM in human breast cancer cells. We show that the MUC1-C cytoplasmic domain binds directly to ATM HEAT repeats. Our results also demonstrate that the MUC1-C cytoplasmic domain binds to the ATM substrate H2AX. The functional significance of these interactions is supported by the finding that MUC1-C promotes removal of IR-induced nuclear γH2AX foci. MUC1-C also protects against IR-induced chromosomal aberrations. In concert with these results, MUC1-C blocks IR-induced death by promoting repair of potentially lethal DNA damage. These findings indicate that the overexpression of MUC1 can protect against IR-induced DNA DSBs and may represent a physiologic response that has been exploited by malignant cells.

Entities:  

Year:  2010        PMID: 20865059      PMCID: PMC2943399          DOI: 10.1177/1947601910368059

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  50 in total

Review 1.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

2.  MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90.

Authors:  J Ren; A Bharti; D Raina; W Chen; R Ahmad; D Kufe
Journal:  Oncogene       Date:  2006-01-05       Impact factor: 9.867

3.  Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.

Authors:  Zhao-Hui Wu; Yuling Shi; Randal S Tibbetts; Shigeki Miyamoto
Journal:  Science       Date:  2006-02-24       Impact factor: 47.728

4.  NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.

Authors:  Junya Kobayashi; Hiroshi Tauchi; Shuichi Sakamoto; Asako Nakamura; Ken-ichi Morishima; Shinya Matsuura; Toshiko Kobayashi; Katsuyuki Tamai; Keiji Tanimoto; Kenshi Komatsu
Journal:  Curr Biol       Date:  2002-10-29       Impact factor: 10.834

5.  Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.

Authors:  Paola D Vermeer; Lisa A Einwalter; Thomas O Moninger; Tatiana Rokhlina; Jeffrey A Kern; Joseph Zabner; Michael J Welsh
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

6.  DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7.

Authors:  Yongqing Li; Wen Chen; Jian Ren; Wei-Hsuan Yu; Quan Li; Kiyotsugu Yoshida; Donald Kufe
Journal:  Cancer Biol Ther       Date:  2003 Mar-Apr       Impact factor: 4.742

7.  The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.

Authors:  Selvi Ramasamy; Sekhar Duraisamy; Sergei Barbashov; Takeshi Kawano; Surender Kharbanda; Donald Kufe
Journal:  Mol Cell       Date:  2007-09-21       Impact factor: 17.970

8.  Human DF3/MUC1 carcinoma-associated protein functions as an oncogene.

Authors:  Yongqing Li; Derek Liu; Dongshu Chen; Surender Kharbanda; Donald Kufe
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

9.  Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62.

Authors:  Yumei Leng; Cheng Cao; Jian Ren; Lei Huang; Dongshu Chen; Masaki Ito; Donald Kufe
Journal:  J Biol Chem       Date:  2007-05-11       Impact factor: 5.157

Review 10.  GammaH2AX and cancer.

Authors:  William M Bonner; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Olga A Sedelnikova; Stéphanie Solier; Yves Pommier
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

View more
  14 in total

1.  MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells.

Authors:  Li Yin; Zekui Wu; David Avigan; Jacalyn Rosenblatt; Richard Stone; Surender Kharbanda; Donald Kufe
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

Review 2.  MUC1 and MUC4: switching the emphasis from large to small.

Authors:  Huguette Albrecht; Kermit L Carraway
Journal:  Cancer Biother Radiopharm       Date:  2011-06       Impact factor: 3.099

3.  MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated Mechanism.

Authors:  Li Yin; Donald Kufe
Journal:  Genes Cancer       Date:  2011-01

4.  MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells.

Authors:  Masaaki Yamamoto; Caining Jin; Tsuyoshi Hata; Yota Yasumizu; Yan Zhang; Deli Hong; Takahiro Maeda; Masaaki Miyo; Masayuki Hiraki; Yozo Suzuki; Kunihiko Hinohara; Hasan Rajabi; Donald Kufe
Journal:  Cancer Res       Date:  2019-03-01       Impact factor: 12.701

5.  Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.

Authors:  Atsushi Fushimi; Yoshihiro Morimoto; Satoshi Ishikawa; Nami Yamashita; Atrayee Bhattacharya; Tatsuaki Daimon; Hasan Rajabi; Caining Jin; Masayuki Hagiwara; Yota Yasumizu; Zhou Luan; Wenhao Suo; Kwok-Kin Wong; Henry Withers; Song Liu; Mark D Long; Donald Kufe
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

6.  The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.

Authors:  Yuan Li; Haiying Yi; Yixin Yao; Xiaodong Liao; Yiqun Xie; Jie Yang; Zheng Yan; Long Wang; Shunyuan Lu; Ying Kuang; Mingmin Gu; Jian Fei; Zhugang Wang; Lei Huang
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

7.  Impact of MUC1 mucin downregulation in the phenotypic characteristics of MKN45 gastric carcinoma cell line.

Authors:  Natália R Costa; Paula Paulo; Thomas Caffrey; Michael A Hollingsworth; Filipe Santos-Silva
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

8.  MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner.

Authors:  Wei Jin; Xiaodong Liao; Yaping Lv; Zhi Pang; Yuming Wang; Quanfu Li; Yahui Liao; Qing Ye; Guoqiang Chen; Kewen Zhao; Lei Huang
Journal:  Cell Death Dis       Date:  2017-08-10       Impact factor: 8.469

9.  MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer.

Authors:  Venugopal Gunda; Joshua Souchek; Jaime Abrego; Surendra K Shukla; Gennifer D Goode; Enza Vernucci; Aneesha Dasgupta; Nina V Chaika; Ryan J King; Sicong Li; Shuo Wang; Fang Yu; Tadayoshi Bessho; Chi Lin; Pankaj K Singh
Journal:  Clin Cancer Res       Date:  2017-07-18       Impact factor: 13.801

10.  Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia.

Authors:  Andrew Dhawan; Seyed Ali Madani Tonekaboni; Joseph H Taube; Stephen Hu; Nathalie Sphyris; Sendurai A Mani; Mohammad Kohandel
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.